Trials / Conditions / Leber Hereditary Optic Neuropathy (LHON)
Leber Hereditary Optic Neuropathy (LHON)
5 registered clinical trials studyying Leber Hereditary Optic Neuropathy (LHON) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy NCT07258667 | University Hospital, Angers | Phase 1 |
| Active Not Recruiting | A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic NCT07406854 | Wuhan Neurophth Biotechnology Limited Company | Phase 3 |
| Terminated | Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutat NCT05820152 | Neurophth Therapeutics Inc | Phase 1 / Phase 2 |
| Active Not Recruiting | Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutat NCT05293626 | Neurophth Therapeutics Inc | Phase 1 / Phase 2 |
| Completed | Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey NCT01892943 | Santhera Pharmaceuticals | — |